seed
Stage
1
Investors
About
Herasight develops genetic screening tools for embryos by applying whole genome sequencing and polygenic risk scoring to help prospective parents assess and reduce the genetic risk of complex and monogenic diseases during IVF.
Explore Herasight's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.